Post Doctoral Opportunity - Ref nr POSTDOC123

Cardiovascular & Metabolic Diseases (CVMD) Molndal, Sweden,

Improving adipose tissue function in type 2 diabetes using novel pharmacological approaches

We're currently looking for talented scientists to join our innovative academic-style postdoc programme which spans a wide range of disciplines and aligns with one of our therapeutic areas. From our centre in Mölndal, Sweden you'll be in a global pharmaceutical environment, working alongside our scientists who are contributing to drug discovery and development and be part of a much larger active global post doc community. You will be encouraged to pursue your own independent research in cutting edge laboratories, present at external meetings, and publish in leading journals. You will also be offered a comprehensive training programme.

What's more, you'll have the support of a leading academic advisor, who'll provide you with the guidance and knowledge you need ensure success of your projects and to help develop your career. This is an exciting opportunity, to work within a Pharmaceutical setting but maintaining a strong basic science focus aligned to drug discovery and development activities, making this an opportunity to make a real difference to the future of medical science.

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines for some of the world's most serious diseases. But we're more than one of the world's leading pharmaceutical companies. At AstraZeneca, we're proud to have a unique workplace culture that inspires innovation and collaboration. Here, employees are empowered to express diverse perspectives - and are made to feel valued, energised and rewarded for their ideas and creativity.

At the Diabetes department within the Cardiovascular and Metabolic Diseases Innovative Medicine Unit, a key strategic research area to treat type 2 diabetes is to restore proper lipid storage in adipose tissues and reduce the negative metabolic consequence of lipid spillover into non adipose tissues. As a post doctoral scientist in the Diabetes department, you will have the opportunity to apply novel pharmalogical approaches to improve adipose tissue function and make a difference to the lives of type 2 diabetic patients. In particular, you will be developing new tools for adipose tissue targeting of drugs, including identifying and characterizing novel ligands to be used for adipose targetingand testing both in vitro and in vivo. You will have the opportunity to work with excellent scientists across many disciplines, and have access to state of the art technology platforms in our facilities. In addition, this is a unique opportunity to participate in, and gain knowledge of, the drug discovery process.

Minimum Requirements

As a Postdoctoral Scientist - Cardiovascular and Metabolic Diseases, you will be:
- Designing, conducting experiments and interpreting results
- Interacting and working with scientists across many disciplines, while at the same time being able to work independently
- Developing ideas, showing motivation and focus
- Communicatingyour results both internally and externally, through presentations at meetings and conferences, and publication in peer reviewed journals

Minimum Requirements, Education and Experience....

To READ FULL JOBDESCRIPTION and TO APPLY:

http://jobs.astrazeneca.com/jobs/details/l1rPOST%20DOC%20123-post-doctoral-opportunity-cardiovascula